开云app官网登录入口网页版-官方正版

#化学疗法#

15篇内容 | 804人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2040590, encodeId=a5922040590d6, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=癌症复发机制揭露，癌细胞可能会进入休眠状态而逃避化学疗法！, objectType=article, longId=208430, objectId=fafb20843067, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fafb20843067, replyNumber=0, likeNumber=65, createdTime=2022-01-30, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fafb20843067, moduleTitle=癌症复发机制揭露，癌细胞可能会进入休眠状态而逃避化学疗法！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fafb20843067)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040588, encodeId=36e620405884e, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=FDA批准Cosela（trilaciclib）用于减少化学疗法引起的骨髓抑制, objectType=article, longId=207132, objectId=3ff420e132a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ff420e132a7, replyNumber=0, likeNumber=82, createdTime=2021-03-09, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ff420e132a7, moduleTitle=FDA批准Cosela（trilaciclib）用于减少化学疗法引起的骨髓抑制, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3ff420e132a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040589, encodeId=d4332040589fd, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=Toripalimab联合化学疗法一线治疗鼻咽癌，中国国家药品监督管理局已批准其补充性新药申请, objectType=article, longId=207388, objectId=e5a120e38811, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5a120e38811, replyNumber=0, likeNumber=72, createdTime=2021-06-20, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5a120e38811, moduleTitle=Toripalimab联合化学疗法一线治疗鼻咽癌，中国国家药品监督管理局已批准其补充性新药申请, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e5a120e38811)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040587, encodeId=9740204058e72, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=基线免疫力和化学疗法对宫颈癌免疫微环境的影响, objectType=article, longId=202689, objectId=9fb7202689b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fb7202689b7, replyNumber=0, likeNumber=40, createdTime=2020-12-03, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fb7202689b7, moduleTitle=基线免疫力和化学疗法对宫颈癌免疫微环境的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9fb7202689b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040585, encodeId=753a2040585e2, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=默克的PD-1单抗Keytruda：一线治疗结肠直肠癌优于化学疗法, objectType=article, longId=191474, objectId=78ce1914e4eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78ce1914e4eb, replyNumber=0, likeNumber=96, createdTime=2020-12-02, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78ce1914e4eb, moduleTitle=默克的PD-1单抗Keytruda：一线治疗结肠直肠癌优于化学疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=78ce1914e4eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040586, encodeId=8b462040586fc, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=DCR：新辅助放化疗和全直肠系膜切除术后，辅助化学疗法不能改善2期或3期直肠癌患者的无复发生存率, objectType=article, longId=192550, objectId=2bcf192550e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bcf192550e6, replyNumber=0, likeNumber=75, createdTime=2021-01-08, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bcf192550e6, moduleTitle=DCR：新辅助放化疗和全直肠系膜切除术后，辅助化学疗法不能改善2期或3期直肠癌患者的无复发生存率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2bcf192550e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040584, encodeId=34dc204058471, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=化学疗法诱发的血小板减少症如何治疗？-FDA授予avatrombopag孤儿药称号, objectType=article, longId=185150, objectId=07e11851505d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07e11851505d, replyNumber=0, likeNumber=50, createdTime=2020-10-04, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07e11851505d, moduleTitle=化学疗法诱发的血小板减少症如何治疗？-FDA授予avatrombopag孤儿药称号, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=07e11851505d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040583, encodeId=ff1520405831c, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=Blood：体外光化学疗法(ECP)可明显改善Sezary综合征和真菌红皮病患者预后, objectType=article, longId=178701, objectId=9cce1e8701ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cce1e8701ce, replyNumber=0, likeNumber=60, createdTime=2020-03-06, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cce1e8701ce, moduleTitle=Blood：体外光化学疗法(ECP)可明显改善Sezary综合征和真菌红皮病患者预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9cce1e8701ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040582, encodeId=65a32040582b9, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=ACS Appl Mater Interfaces：光动力学和化学疗法的自组装奥沙利铂（IV）前药 - 卟啉缀合物可有效用于癌症的治疗, objectType=article, longId=164683, objectId=2d98164683f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d98164683f4, replyNumber=0, likeNumber=73, createdTime=2020-01-28, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d98164683f4, moduleTitle=ACS Appl Mater Interfaces：光动力学和化学疗法的自组装奥沙利铂（IV）前药 - 卟啉缀合物可有效用于癌症的治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2d98164683f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040581, encodeId=43062040581c1, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=2017 WHO指南：预防性化学疗法控制风险人群土源性寄生虫感染, objectType=article, longId=117476, objectId=37c711e476bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37c711e476bf, replyNumber=0, likeNumber=53, createdTime=2018-06-08, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37c711e476bf, moduleTitle=2017 WHO指南：预防性化学疗法控制风险人群土源性寄生虫感染, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=37c711e476bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040580, encodeId=fa43204058002, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=ACS Appl Mater Interfaces：新型Janus纳米材料可整合光热疗法和化学疗法以更好的治疗肝癌, objectType=article, longId=113330, objectId=22c111333077, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22c111333077, replyNumber=0, likeNumber=73, createdTime=2017-12-23, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22c111333077, moduleTitle=ACS Appl Mater Interfaces：新型Janus纳米材料可整合光热疗法和化学疗法以更好的治疗肝癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=22c111333077)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040578, encodeId=868120405e8aa, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=NEJM：突破！单克隆抗体药物治疗恶性白血病疗效或明显优于化学疗法, objectType=article, longId=90592, objectId=bd9f9059261, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd9f9059261, replyNumber=0, likeNumber=68, createdTime=2017-09-19, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd9f9059261, moduleTitle=NEJM：突破！单克隆抗体药物治疗恶性白血病疗效或明显优于化学疗法, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=bd9f9059261)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040579, encodeId=5a6e20405e961, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=Oncotarget：Elenagen疫苗在晚期实体瘤治疗中表现安全性和抗肿瘤活性，并能恢复肿瘤对化学疗法的敏感性, objectType=article, longId=100552, objectId=168c1005523e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=168c1005523e, replyNumber=0, likeNumber=83, createdTime=2017-10-17, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=168c1005523e, moduleTitle=Oncotarget：Elenagen疫苗在晚期实体瘤治疗中表现安全性和抗肿瘤活性，并能恢复肿瘤对化学疗法的敏感性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=168c1005523e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040577, encodeId=c3a120405e786, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=ACS Nano：新型诊断成像技术助化学疗法杀灭前列腺癌细胞, objectType=article, longId=8924, objectId=e301892405, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e301892405, replyNumber=0, likeNumber=60, createdTime=2013-07-10, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e301892405, moduleTitle=ACS Nano：新型诊断成像技术助化学疗法杀灭前列腺癌细胞, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e301892405)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2040576, encodeId=90cb20405e66b, content=<a href='/topic/show?id=70d83351235' target=_blank style='color:#2F92EE;'>#化学疗法#</a>, objectTitle=应用减瘤手术和化学疗法成功治疗小肠腺癌的复发, objectType=article, longId=2647, objectId=264d264e1f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=264d264e1f, replyNumber=0, likeNumber=117, createdTime=2011-07-28, rootId=0, userName=chg121, userId=d7db99, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=264d264e1f, moduleTitle=应用减瘤手术和化学疗法成功治疗小肠腺癌的复发, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=264d264e1f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

化学疗法

2020-05-29

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

癌症复发机制揭露，癌细胞可能会进入休眠状态而逃避化学疗法！

2022-01-30

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

FDA批准Cosela（trilaciclib）用于减少化学疗法引起的骨髓抑制

2021-03-09

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

Toripalimab联合化学疗法一线治疗鼻咽癌，中国国家药品监督管理局已批准其补充性新药申请

2021-06-20

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

基线免疫力和化学疗法对宫颈癌免疫微环境的影响

2020-12-03

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

默克的PD-1单抗Keytruda：一线治疗结肠直肠癌优于化学疗法

2020-12-02

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

DCR：新辅助放化疗和全直肠系膜切除术后，辅助化学疗法不能改善2期或3期直肠癌患者的无复发生存率

2021-01-08

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

化学疗法诱发的血小板减少症如何治疗？-FDA授予avatrombopag孤儿药称号

2020-10-04

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

Blood：体外光化学疗法(ECP)可明显改善Sezary综合征和真菌红皮病患者预后

2020-03-06

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

ACS Appl Mater Interfaces：光动力学和化学疗法的自组装奥沙利铂（IV）前药 - 卟啉缀合物可有效用于癌症的治疗

2020-01-28

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

2017 WHO指南：预防性化学疗法控制风险人群土源性寄生虫感染

2018-06-08

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

ACS Appl Mater Interfaces：新型Janus纳米材料可整合光热疗法和化学疗法以更好的治疗肝癌

2017-12-23

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

NEJM：突破！单克隆抗体药物治疗恶性白血病疗效或明显优于化学疗法

2017-09-19

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

Oncotarget：Elenagen疫苗在晚期实体瘤治疗中表现安全性和抗肿瘤活性，并能恢复肿瘤对化学疗法的敏感性

2017-10-17

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

ACS Nano：新型诊断成像技术助化学疗法杀灭前列腺癌细胞

2013-07-10

chg121 (审核中...)

前往app查看评论内容

#化学疗法#

应用减瘤手术和化学疗法成功治疗小肠腺癌的复发

2011-07-28

科室
- - 订阅+
  - 更多科室
工具
服务